Toshiba expects to complete chip unit sale by June at latest:…

Technology


YOKKAICHI, Japan (Reuters) – Toshiba Corp (6502.T) expects the sale of its $18 billion memory chip business to be completed by June at the latest, if not by an agreed deadline of the end of March, as it awaits antitrust regulatory approval from China.

FILE PHOTO: A logo of Toshiba Corp is seen on a printed circuit board in this photo illustration taken in Tokyo July 31, 2012. REUTERS/Yuriko Nakao/File Photo

“We’ve been making various efforts to close the deal in March,” Yasuo Naruke, the head of Toshiba’s chip unit, told reporters on Friday.

Even if the deal did not close by then, it would close “at some point in April, May or June,” Naruke said during his visit to a new chip R&D center in central Japan.

Toshiba agreed last year to sell the semiconductor business – the world’s second-biggest producer of NAND flash memory chips – to a consortium led by U.S. private equity firm Bain Capital to plug a huge financial hole left by the bankruptcy of its U.S. nuclear unit.

It is widely viewed as unlikely to gain the necessary regulatory clearance by the end of the financial year in March, however, as Chinese reviews usually take at least six months.

Toshiba is in less of a rush to finalize the deal since it received injections of capital late last year from overseas investors. If it does not complete the deal by March, it has the option of walking away, sources have said.

Some activist shareholders have opposed the sale, arguing that the fresh capital made it unnecessary.

The flash memory chip business has been the source of most of Toshiba’s earnings as the company struggles to grow other core businesses such as social infrastructure.

Reporting by Makiko Yamazaki; Editing by Stephen Coates



Source link

Products You May Like

Articles You May Like

Trump approves disaster aid for Hawaii
Lopetegui fired by Spain two days before World Cup debut, Hierro…
Colorado wildfires displace thousands, prompt national forest closure
Italy court rules it cannot hear Morgan Stanley derivatives case
Orange, former executives to stand trial over staff suicides

Leave a Reply

Your email address will not be published. Required fields are marked *